Midazolam recalls
Midazolam products have been recalled 3 times, most recently on 10 Jan 2018. The recalling company is usually Fresenius Kabi USA. The most common reason is packaging defects.
Total recalls3since 2014
Last 12 months0reported
Class I133% of total
Ongoing0latest 10 Jan 2018
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 33%Class II 2 67%Class III 0 0%
Why midazolam is recalled
Companies
Product types
By year
All midazolam recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Midazolam Injection, USP, Preservative Free, 2 mg recalledMidazolam | Fresenius Kabi USA | Packaging Defects | Nationwide |
| Drug | CLASS II | Midazolam Injection, USP, *25 mg/, (5 mg/ mL) vials, 10 Vials recalledMidazolam | Fresenius Kabi USA | Potency & Assay | Nationwide |
| Drug | CLASS II | Midazolam Hydrochloride Injection, 5 mg/, C-iv recalledMidazolam | Fresenius Kabi USA | Particulate Matter | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.